Anti-fibrotic effect and in vivo target engagement of Nintedanib administered by oral gavage or by a medicated diet in a bleomycin lung fibrosis model in the rat
M. Trevisani (Parma, Italy), P. Caruso (Parma, Italy), V. Pitozzi (Parma, Italy), S. Pontis (Parma, Italy), M. Pittelli (Parma, Italy), M. Bonatti (Parma, Italy), G. Villetti (Parma, Italy), M. Civelli (Parma, Italy)
Source: International Congress 2022 – In vivo and in vitro studies of airway diseases
Session: In vivo and in vitro studies of airway diseases
Session type: Thematic Poster
Number: 3160
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Trevisani (Parma, Italy), P. Caruso (Parma, Italy), V. Pitozzi (Parma, Italy), S. Pontis (Parma, Italy), M. Pittelli (Parma, Italy), M. Bonatti (Parma, Italy), G. Villetti (Parma, Italy), M. Civelli (Parma, Italy). Anti-fibrotic effect and in vivo target engagement of Nintedanib administered by oral gavage or by a medicated diet in a bleomycin lung fibrosis model in the rat. 3160
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|